• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纽约州的人类巴贝斯虫病:139例住院病例回顾及预后因素分析。

Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors.

作者信息

White D J, Talarico J, Chang H G, Birkhead G S, Heimberger T, Morse D L

机构信息

Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany 12201-0509, USA.

出版信息

Arch Intern Med. 1998 Oct 26;158(19):2149-54. doi: 10.1001/archinte.158.19.2149.

DOI:10.1001/archinte.158.19.2149
PMID:9801183
Abstract

BACKGROUND

Babesiosis infections are infrequent, occur in limited geographic locations, and range from asymptomatic infection to severe illness and death.

METHODS

Descriptive clinical and epidemiological information on human babesiosis cases was collated from state communicable disease reports and medical records of patients hospitalized from 1982 to 1993. Univariate and multivariate analyses were performed to determine prognostic factors associated with severe disease outcome (hospitalization ending in death, duration of hospitalization > 14 days, or intensive care unit stay > 2 days).

RESULTS

Between 1982 and 1993, 139 patients were hospitalized with babesiosis in New York State. Nine patients (6.5%) died, 35 (25.2%) were admitted to the intensive care unit, and 35 (25.2%) required hospitalization for more than 14 days. Mean age at first hospitalization was 62.5 years. Sixty-two percent were male, and 91% resided in Suffolk County, Long Island. The most common symptoms were fatigue/malaise/weakness (91%), fever (91%), shaking chills (77%), and diaphoresis (69%). Past medical records showed that 52% of patients had a history of chronic disease; 12% had a history of Lyme disease; 12% had undergone a splenectomy; and 2% had undergone a blood transfusion. There was a 12- to 14-day delay between onset of symptoms and initiation of appropriate antibiotic treatment. Univariate analyses showed alkaline phosphatase levels greater than 125 U/L, white blood cell counts greater than 5 x 10(9)/L, history of cardiac abnormality, history of splenectomy, presence of heart murmur, and parasitemia values of 0.04 or higher to be significantly associated with disease severity. Multiple logistic regression analyses indicated that male sex, alkaline phosphatase values greater than 125 U/L, and white blood cell counts greater than 5 x 10(9)/L remained strong predictors of severe outcome.

CONCLUSIONS

Human babesiosis is a rare but debilitating and potentially fatal illness, especially in the elderly. Prompt disease diagnosis and treatment are essential but are often delayed, as seen in our series. This delay reinforces the need for enhanced public and physician education targeted toward residents and visitors to the few high-risk geographic areas where disease and Ixodes scapularis ticks are endemic. Patients presenting with certain prognostic indicators (male sex, alkaline phosphatase values > 125 U/L, and white blood cell counts >5 x 10(9)/L) require comprehensive and aggressive medical care to prevent further deterioration. Since babesiosis is only 1 of 3 currently recognized diseases transmitted by I scapularis ticks, primary prevention recommendations will also reduce human exposure to Lyme disease and human granulocytic ehrlichiosis.

摘要

背景

巴贝斯虫感染并不常见,发生在有限的地理位置,范围从无症状感染到严重疾病甚至死亡。

方法

从1982年至1993年的州传染病报告和住院患者的病历中整理出关于人类巴贝斯虫病病例的描述性临床和流行病学信息。进行单变量和多变量分析以确定与严重疾病结局(住院以死亡告终、住院时间>14天或重症监护病房停留>2天)相关的预后因素。

结果

1982年至1993年期间,纽约州有139例患者因巴贝斯虫病住院。9例(6.5%)死亡,35例(25.2%)入住重症监护病房,35例(25.2%)需要住院超过14天。首次住院时的平均年龄为62.5岁。62%为男性,91%居住在长岛的萨福克县。最常见的症状是疲劳/不适/虚弱(91%)、发热(91%)、寒战(77%)和出汗(69%)。既往病历显示,52%的患者有慢性病病史;12%有莱姆病病史;12%接受过脾切除术;2%接受过输血。症状出现与开始适当抗生素治疗之间有12至14天的延迟。单变量分析显示,碱性磷酸酶水平大于125 U/L、白细胞计数大于5×10⁹/L、心脏异常病史、脾切除术病史、心脏杂音的存在以及寄生虫血症值为0.04或更高与疾病严重程度显著相关。多因素逻辑回归分析表明,男性、碱性磷酸酶值大于125 U/L以及白细胞计数大于5×10⁹/L仍然是严重结局的有力预测因素。

结论

人类巴贝斯虫病是一种罕见但使人衰弱且可能致命的疾病,尤其是在老年人中。及时的疾病诊断和治疗至关重要,但正如我们系列研究中所见,往往会延迟。这种延迟强化了对少数疾病和肩突硬蜱流行的高风险地理区域的居民和访客加强公众和医生教育的必要性。出现某些预后指标(男性、碱性磷酸酶值>125 U/L和白细胞计数>5×10⁹/L)的患者需要全面且积极的医疗护理以防止病情进一步恶化。由于巴贝斯虫病只是目前已知由肩突硬蜱传播的三种疾病之一,一级预防建议也将减少人类接触莱姆病和人类粒细胞埃立克体病的机会。

相似文献

1
Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors.纽约州的人类巴贝斯虫病:139例住院病例回顾及预后因素分析。
Arch Intern Med. 1998 Oct 26;158(19):2149-54. doi: 10.1001/archinte.158.19.2149.
2
Human babesiosis in New York State: an epidemiological description of 136 cases.纽约州的人类巴贝斯虫病:136例病例的流行病学描述。
Clin Infect Dis. 1992 Dec;15(6):1019-23. doi: 10.1093/clind/15.6.1019.
3
Babesiosis Surveillance - Wisconsin, 2001-2015.2001 - 2015年威斯康星州巴贝斯虫病监测
MMWR Morb Mortal Wkly Rep. 2017 Jul 7;66(26):687-691. doi: 10.15585/mmwr.mm6626a2.
4
Babesiosis Surveillance - United States, 2011-2015.巴贝虫病监测-美国,2011-2015 年。
MMWR Surveill Summ. 2019 May 31;68(6):1-11. doi: 10.15585/mmwr.ss6806a1.
5
Babesiosis in Lower Hudson Valley, New York, USA.美国纽约下哈德逊谷的巴贝斯虫病。
Emerg Infect Dis. 2011 May;17(5):843-7. doi: 10.3201/eid1705.101334.
6
Fever of unknown origin (FUO) due to babesiosis in a immunocompetent host.免疫功能正常宿主因巴贝斯虫病导致的不明原因发热(FUO)。
Heart Lung. 2008 Nov-Dec;37(6):481-4. doi: 10.1016/j.hrtlng.2008.01.003. Epub 2008 Sep 30.
7
Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone.长岛的巴贝斯虫病:62例病例回顾,重点关注阿奇霉素和阿托伐醌的治疗
Ann Clin Microbiol Antimicrob. 2017 Apr 11;16(1):26. doi: 10.1186/s12941-017-0198-9.
8
Transfusion-Transmitted Babesiosis During Total Hip Arthroplasty.全髋关节置换术中输血传播的巴贝斯虫病
Orthopedics. 2015 Sep;38(9):e852-5. doi: 10.3928/01477447-20150902-92.
9
Transfusion-associated transmission of babesiosis in New York State.纽约州输血相关的巴贝斯虫病传播
Transfusion. 2000 Mar;40(3):285-9. doi: 10.1046/j.1537-2995.2000.40030285.x.
10
Transfusion-transmitted and community-acquired babesiosis in New York, 2004 to 2015.2004年至2015年纽约的输血传播和社区获得性巴贝斯虫病
Transfusion. 2018 Mar;58(3):660-668. doi: 10.1111/trf.14476. Epub 2018 Jan 31.

引用本文的文献

1
Missed Until Critical: Unravelling the Mystery of Persistent Hemolysis With a Definitive Diagnosis of Babesiosis.直至危急时才被发现:通过确诊巴贝斯虫病解开持续性溶血之谜。
Cureus. 2025 Jun 19;17(6):e86381. doi: 10.7759/cureus.86381. eCollection 2025 Jun.
2
Severe Thrombocytopenia Secondary to Babesiosis: A Case Report.巴贝斯虫病继发严重血小板减少症:一例报告
Case Rep Hematol. 2025 Jul 1;2025:9918329. doi: 10.1155/crh/9918329. eCollection 2025.
3
From Tick Bite to Broken Heart: A Case of Stress Cardiomyopathy Induced by Severe Babesiosis.
从蜱虫叮咬到心碎:一例由严重巴贝斯虫病诱发的应激性心肌病病例
Cureus. 2025 May 22;17(5):e84612. doi: 10.7759/cureus.84612. eCollection 2025 May.
4
Pulmonary Manifestations of Babesiosis and Predictors of Mortality from a Quaternary Care Center in Westchester, New York.纽约韦斯特切斯特一家四级医疗中心巴贝斯虫病的肺部表现及死亡率预测因素
Pathogens. 2025 Apr 12;14(4):376. doi: 10.3390/pathogens14040376.
5
Comparative ecological analysis and predictive modeling of tick-borne pathogens.蜱传病原体的比较生态分析与预测建模
J Med Entomol. 2025 Jan 13;62(1):199-206. doi: 10.1093/jme/tjae127.
6
Beyond Human Babesiosis: Prevalence and Association of Coinfection with Mortality in the United States, 2015-2022: A Retrospective Cohort Study.超越人类巴贝斯虫病:2015 - 2022年美国共感染的患病率及其与死亡率的关联:一项回顾性队列研究
Open Forum Infect Dis. 2024 Oct 8;11(10):ofae504. doi: 10.1093/ofid/ofae504. eCollection 2024 Oct.
7
Immune Control in Repeated Infection in a Patient With B-Cell Deficiency.B细胞缺陷患者反复感染中的免疫控制
Open Forum Infect Dis. 2023 Nov 13;11(1):ofad568. doi: 10.1093/ofid/ofad568. eCollection 2024 Jan.
8
Infections and Acute Kidney Injury: A Global Perspective.感染与急性肾损伤:全球视角。
Semin Nephrol. 2023 Sep;43(5):151466. doi: 10.1016/j.semnephrol.2023.151466. Epub 2023 Dec 28.
9
Transfusion-transmitted spp.: a changing landscape of epidemiology, regulation, and risk mitigation.经输血传播的 spp.:流行病学、监管和风险缓解的变化格局。
J Clin Microbiol. 2023 Oct 24;61(10):e0126822. doi: 10.1128/jcm.01268-22. Epub 2023 Sep 26.
10
Protective efficacy and correlates of immunity of immunodominant recombinant antigens.免疫优势重组抗原的保护效力和免疫相关性。
Infect Immun. 2023 Oct 17;91(10):e0016223. doi: 10.1128/iai.00162-23. Epub 2023 Sep 20.